Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.49 USD | -11.35% | -12.90% | -65.31% |
04-16 | Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04-11 | North American Morning Briefing : Stock Futures -2- | DJ |
Business Summary
Number of employees: 20
Managers
Managers | Title | Age | Since |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 31/01/16 |
Eric Curtis
COO | Chief Operating Officer | 56 | 08/03/20 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Steven Simonson
CTO | Chief Tech/Sci/R&D Officer | 65 | 19/05/14 |
Jamie McAndrew
AUD | Comptroller/Controller/Auditor | 44 | 31/10/13 |
Diane Carman
LAW | General Counsel | 55 | 30/06/21 |
Tracy Rarick
PRN | Corporate Officer/Principal | - | 20/07/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 02/02/21 |
Mark Strobeck
BRD | Director/Board Member | 53 | 21/06/23 |
Leslie Williams
BRD | Director/Board Member | 64 | 02/02/21 |
Craig Fraser
CEO | Chief Executive Officer | 59 | 31/01/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 510,178 | 486,423 ( 95.34 %) | 0 ( 0.000011 %) | 95.34 % |
Company contact information
Windtree Therapeutics, Inc.
2600 Kelly Road Suite 100
18976-3622, Warrington
+
http://www.windtreetx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-65.31% | 2.58M | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- WINT Stock
- Company Windtree Therapeutics, Inc.